{"patient_id": 150570, "patient_uid": "4766801-2", "PMID": 26958424, "file_path": "noncomm/PMC004xxxxxx/PMC4766801.xml", "title": "Do we need to establish guidelines for patients with neuromodulation implantable devices, including spinal cord stimulators undergoing nonspinal surgeries?", "patient": "A 59-year-old female with a history of chronic debilitating back pain and a Medtronic SCS placement in April, 2012 by the interventional pain management team, presented for right total hip arthroplasty surgery.\\nPrecautions were taken, and the device was switched off prior to entering the OR, bipolar cautery was used, and grounding pads were placed >10 cm away from her IPG site.\\nThe surgeon was made aware of the preexisting SCS, but was uncertain of whether hammering and manipulation of her hip could be safely done without dislodging the leads. A last minute literature search did not reveal any additional information or guidelines regarding the management of the SCS system under such circumstances.\\nSurgery proceeded uneventfully and the patient was sent for immediate pain clinic follow-up to re-evaluate device function.", "age": "[[59.0, 'year']]", "gender": "F", "relevant_articles": "{'24773384': 1, '21992157': 1, '17555167': 1, '21719293': 1, '11388106': 1, '16042939': 1, '9894659': 1, '26218762': 1, '10985267': 1, '14585255': 1, '16118386': 1, '21585593': 1, '9491118': 1, '22151142': 1, '22780956': 1, '24176957': 1, '25957536': 1, '15209793': 1, '17463138': 1, '33395503': 1, '11405899': 1, '9801398': 1, '15262047': 1, '14970153': 1, '20966684': 1, '15087724': 1, '10750133': 1, '16434814': 1, '12418748': 1, '24112886': 1, '26958424': 2}", "similar_patients": "{'4766801-1': 2}"}